Body dysmorphic disorders
News
21.01.2021
Asclepion Laser Technologies: Innovative partner for your aesthetic practice
To develop innovative and successful products is the ethos of Asclepion Laser Technologies. Therefore, the company invests intensively in research and medical practice. The goal is to make the advantages […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
24.04.2017
Hologic Completes Acquisition of Cynosure
„We are pleased to complete our acquisition of Cynosure, and look forward to working with Michael Davin and the entire Cynosure team to achieve even greater success in the large, rapidly growing medical […]